Romosozumab
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11866 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 11 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | obsolete vitamin D deficiency | KG + DL |
| 2 | calcium-alkali syndrome | KG + DL |
| 3 | primary bone dysplasia with defective bone mineralization | KG + DL |
| 4 | severe nonproliferative diabetic retinopathy | KG + DL |
| 5 | renal osteodystrophy | KG + DL |
| 6 | osteomalacia (disease) | KG + DL |
| 7 | pregnancy associated osteoporosis | KG + DL |
| 8 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 9 | Worth syndrome | KG + DL |
| 10 | impaired renal function disease | KG + DL |
| 11 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.